Targeting the immunoregulator SRA/CD204 potentiates specific dendritic cell vaccine-induced T-cell response and antitumor immunity
about
Scavenger Receptors: Emerging Roles in Cancer Biology and ImmunologyHigh molecular weight stress proteins: Identification, cloning and utilisation in cancer immunotherapyTherapeutic cancer vaccines: past, present, and futureMetabolic influences that regulate dendritic cell function in tumorsScavenger receptor A restrains T-cell activation and protects against concanavalin A-induced hepatic injuryIn situ vaccination with CD204 gene-silenced dendritic cell, not unmodified dendritic cell, enhances radiation therapy of prostate cancerSmall molecule inhibits activity of scavenger receptor A: Lead identification and preliminary studiesScavenger receptor SREC-I mediated entry of TLR4 into lipid microdomains and triggered inflammatory cytokine release in RAW 264.7 cells upon LPS activationMDA-7/IL-24 functions as a tumor suppressor gene in vivo in transgenic mouse models of breast cancer.The role of heat shock proteins in antigen cross presentation.siRNA and cancer immunotherapy.A review of histiocytic diseases of dogs and cats.Antigen-specific vaccines for cancer treatment.Design, synthesis, and characterization of rhein analogs as novel inhibitors of scavenger receptor A.A multifunctional chimeric chaperone serves as a novel immune modulator inducing therapeutic antitumor immunity.Antagonizing the innate pattern recognition receptor CD204 to improve dendritic cell-targeted cancer immunotherapy.Understanding molecular interactions between scavenger receptor A and its natural product inhibitors through molecular modeling studies.Strategies to Improve the Efficacy of Dendritic Cell-Based Immunotherapy for Melanoma.Systemic administration of β-glucan of 200 kDa modulates melanoma microenvironment and suppresses metastatic cancer.
P2860
Q26799114-C584FE83-251E-4EE3-BD09-7150973FD346Q26853566-A6E97144-2904-43FF-A58C-2F83C41661BBQ26863283-109EB8CC-6CC5-4B14-B0DE-8BF1618E664CQ27011306-D1157376-6F0F-479C-81E3-9A3FA5A64DB2Q28390663-3BC8F980-26B1-449F-810F-B1E82D3E18A9Q28390899-CDAD4DA4-8B1D-4AF0-9AD7-DABE8027143EQ28397940-03F6FCF4-A151-43C0-834D-0B67CFDAD836Q35594232-D58CFEEC-FC53-4425-97F2-91783196FFD3Q36545635-E1D37EDA-73CF-4C56-8773-67B6CB9A4584Q38008364-18AABA96-4C31-43DE-8D4E-7216C5AAF521Q38050504-A051EBD5-F672-4AD0-83BC-C1DC4B3C83E0Q38176339-9B8A16A7-D971-4960-A56F-7C29F202F659Q38284692-E43AC121-0509-48B8-87BB-79F257C621BAQ38729098-22DE3611-8BB7-45BF-9DB6-19D5CDE034DBQ39649593-B5B505BA-E0E2-4186-A146-B0D68F746BB8Q42321652-284C0C05-3FE8-478C-8E05-79333A70589CQ45066494-F32254FF-A709-43FA-B06F-C2AC170C4080Q47135720-9EB9A55E-1BAB-4964-A350-DC97B7842896Q47195452-27077CE6-481A-4ABB-8A50-605BDDE94A17
P2860
Targeting the immunoregulator SRA/CD204 potentiates specific dendritic cell vaccine-induced T-cell response and antitumor immunity
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Targeting the immunoregulator ...... esponse and antitumor immunity
@ast
Targeting the immunoregulator ...... esponse and antitumor immunity
@en
type
label
Targeting the immunoregulator ...... esponse and antitumor immunity
@ast
Targeting the immunoregulator ...... esponse and antitumor immunity
@en
prefLabel
Targeting the immunoregulator ...... esponse and antitumor immunity
@ast
Targeting the immunoregulator ...... esponse and antitumor immunity
@en
P2093
P2860
P1433
P1476
Targeting the immunoregulator ...... esponse and antitumor immunity
@en
P2093
Chunqing Guo
Daming Zuo
John R Subjeck
Masoud H Manjili
Paul B Fisher
Xiang-Yang Wang
P2860
P304
P356
10.1158/0008-5472.CAN-11-1801
P407
P50
P577
2011-09-13T00:00:00Z